Concepedia

Publication | Open Access

LBA55 Trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutant metastatic non-small cell lung cancer (NSCLC): Interim results from the phase 2 DESTINY-Lung02 trial

59

Citations

0

References

2022

Year

No additional data available for this publication yet. Check back later!